HTG Molecular Diagnostics, Inc. Overview
Pro stress-test →HTG Molecular Diagnostics is a life sciences company providing instruments, consumables, and software that automate sample processing and profile various molecular targets for precision medicine applications. The company's lead platform, HTG Edge, can analyze more than 2,500 genes from extremely small clinical samples, either tissue samples or liquid biopsy.
Strategic Profile
Pro stress-test →The company is focused on advancing precision medicine and drug discovery through its transcriptome-wide profiling and advanced drug discovery platform technologies. It distributes its instruments and consumables directly in the United States and Europe, serving biopharmaceutical companies, academic research centers, and molecular testing laboratories.
Competitive Landscape
Pro stress-test →Competitors include Bio-Techne, SeraCare, QIAGEN, Unchained Labs, and ABM (Canada), with the broader competitive landscape also including Illumina as a market leader in genomics. HTG differentiates through its miniaturized sample processing for gene expression profiling, though larger diversified players dominate the broader molecular diagnostics market.
Industry Context
HTG Molecular Diagnostics, Inc. operates in Molecular Diagnostics & Precision Medicine.
Key facts
Founded: 1997 · Headquarters: Tucson, US · Employees: 107 · Revenue: $6.21M · Market cap: N/A